首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
secondary Sjogren's syndrome相关文献:
Sjogren's syndrome: a systemic autoimmune disease.
Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, Indiveri F, Puppo F.
Clin Exp Med. 2022 Feb;22(1):9-25. doi: 10.1007/s10238-021-00728-6. Epub 2021 Jun 7.
PMID:34100160
The Diagnosis and Treatment of Sjogren's Syndrome.
Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T.
Dtsch Arztebl Int. 2017 May 26;114(20):354-361. doi: 10.3238/arztebl.2017.0354.
PMID:28610655
Non-primary Sjogren's Syndrome: Secondary or associated?
Felten R, Meyer A, Gottenberg JE.
Joint Bone Spine. 2023 Mar;90(2):105502. doi: 10.1016/j.jbspin.2022.105502. Epub 2022 Dec 1.
PMID:36464213
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome.
Ann Rheum Dis. 2002 Jun;61(6):554-8. doi: 10.1136/ard.61.6.554.
PMID:12006334
Sjogren's syndrome.
Balint G, Watson Buchanan W, Kean CA, Kean W, Rainsford KD.
Inflammopharmacology. 2024 Feb;32(1):37-43. doi: 10.1007/s10787-023-01222-z. Epub 2023 May 17.
PMID:37195497
Equal rights in autoimmunity: is Sjogren's syndrome ever 'secondary'?
Kollert F, Fisher BA.
Rheumatology (Oxford). 2020 Jun 1;59(6):1218-1225. doi: 10.1093/rheumatology/keaa009.
PMID:32025734
Primary Sjogren's syndrome.
Bowman SJ.
Lupus. 2018 Oct;27(1_suppl):32-35. doi: 10.1177/0961203318801673.
PMID:30452329
Sjogren's syndrome.
Manthorpe R, Jacobsson LT.
Baillieres Clin Rheumatol. 1995 Aug;9(3):483-96. doi: 10.1016/s0950-3579(05)80254-7.
PMID:7497534
Sjogren's syndrome.
Rehman HU.
Yonsei Med J. 2003 Dec 30;44(6):947-54. doi: 10.3349/ymj.2003.44.6.947.
PMID:14703600
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjogren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
Dörner T, Kaul M, Szántó A, Tseng JC, Papas AS, Pylvaenaeinen I, Hanser M, Abdallah N, Grioni A, Santos Da Costa A, Ferrero E, Gergely P, Hillenbrand R, Avrameas A, Cenni B, Siegel RM.
Ann Rheum Dis. 2024 Feb 15;83(3):360-371. doi: 10.1136/ard-2023-224691.
PMID:37932009
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3